What is the drug name of Bosutinib/Bosutinib?

Bosutinib and bosutinib are not actually two different drugs, but different transliterations of the same drug in the Chinese context. Its international generic name is Bosutinib, which is the official generic name with legal and medical significance used worldwide. Bosutinib is used as the standard name in overseas drug registrations, medical literature, and treatment guidelines. The Chinese names "bosutinib" or "bosutinib" appear more often in translation systems or patient communications in different regions. There is no difference between the two in terms of ingredients, pharmacological properties and clinical positioning.

In terms of trade name,Bosutinib’s original trade name is BOSULIF, which is mainly used in overseas markets, including Europe, the United States and some emerging pharmaceutical markets. BOSULIF is often associated with the originator version produced by Pfizer and is a common designation on physician prescriptions and international drug distribution. It should be noted that the trade name is not equivalent to the medical properties of the drug itself. What truly determines the efficacy and indications of the drug is still its generic name and active ingredients.

From the perspective of drug categories, bosutinib is a tyrosine kinase inhibitor and a typical molecular targeted therapy drug. It is mainly used to treat Philadelphia chromosome-positive chronic myelogenous leukemia and occupies an important position in the treatment system of hematological tumors. The drug can be used not only for newly diagnosed patients in the chronic phase, but also for patients who have developed resistance or intolerance to previous treatments, and also covers some adult patients in the progressive stage of the disease. In some countries and regions, Bosutinib has also been approved for use in pediatric patients of specific age groups, reflecting its application value in the full-course management of the disease.

Overall, understanding the relationship between the generic name, trade name and Chinese translation of Bosutinib can help patients avoid confusion and misunderstanding when checking information, consulting doctors or obtaining overseas drug information.

Keyword tags: What is bosutinib, generic name of bosutinib, Bosutinib trade name, BOSULIF description, chronic myelogenous leukemia targeted drug, Ph+ CML treatment

Reference materials:https://labeling.pfizer.com/ShowLabeling.aspx?id=17463